Bnc Wealth Management, LLC Zynerba Pharmaceuticals, Inc. Transaction History

Bnc Wealth Management, LLC

  • $271 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Mar 05, 2021
SELL
$3.27 - $4.64 $654 - $927
-200 Closed
0 $0
Q3 2020

Nov 17, 2020
BUY
$3.23 - $4.3 $646 - $860
200 New
200 $1,000

Others Institutions Holding ZYNE

# of Institutions
4
Shares Held
774K
Call Options Held
0
Put Options Held
0
View Full List

About Zynerba Pharmaceuticals, Inc.

ZYNE Quotes by TradingView
  • Ticker ZYNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,753,100
  • Description
  • Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...
More about ZYNE
Track This Portfolio

Track Bnc Wealth Management, LLC Portfolio

Follow Bnc Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bnc Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bnc Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email